Literature DB >> 17726367

P21(WAF1/CIP1) may be a tumor suppressor after all.

Andrei L Gartel1.   

Abstract

The cyclin-dependent kinase inhibitor p21WAF1/CIP1 was originally considered to be a tumor-suppressor because it was identified as a key mediator of p53-dependent cell cycle arrest. However, it has been suggested that p21 may also act as an oncogene because it often inhibits apoptosis. For example, deletion of p21 from p53-deficient mice resulted in longer survival and in a significantly reduced number of thymic lymphomas that was explained by higher apoptotic rates in these mice. However, recently it has been shown that a p53 mutant that had lost its ability to induce apoptosis, but retained its ability to induce p21 and cell cycle arrest, was able to suppress lymphomagenesis in different cancer models. Tumor suppression by this p53 mutant was modulated by p21, which induced senescence and preserved chromosomal stability. These data suggest that the ability of p21 to induce cell-cycle arrest may lead to tumor suppression in some types of cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726367     DOI: 10.4161/cbt.6.8.4712

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  6 in total

1.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

2.  Dietary restriction attenuates the accelerated aging phenotype of Sod1(-/-) mice.

Authors:  Yiqiang Zhang; Yuji Ikeno; Alex Bokov; Jon Gelfond; Carlos Jaramillo; Hong-Mei Zhang; Yuhong Liu; Wenbo Qi; Gene Hubbard; Arlan Richardson; Holly Van Remmen
Journal:  Free Radic Biol Med       Date:  2013-02-28       Impact factor: 7.376

Review 3.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

4.  NORE1A tumor suppressor candidate modulates p21CIP1 via p53.

Authors:  Diego F Calvisi; Howard Donninger; Michele D Vos; Michael J Birrer; Laura Gordon; Virna Leaner; Geoffrey J Clark
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

Review 5.  BRCA1 and p53 tumor suppressor molecules in Alzheimer's disease.

Authors:  Atsuko Nakanishi; Akari Minami; Yasuko Kitagishi; Yasunori Ogura; Satoru Matsuda
Journal:  Int J Mol Sci       Date:  2015-01-28       Impact factor: 5.923

6.  Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation.

Authors:  Richard L Momparler; Sylvie Côté; Louise F Momparler; Youssef Idaghdour
Journal:  Clin Epigenetics       Date:  2014-10-01       Impact factor: 6.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.